SCHEMBL5840128

SCHEMBL5840128

CCN1CCc2c(Br)cccc2C1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.56
MAPT P10636 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
POLB P06746 1/20 0.45
PARP10 Q53GL7 1/20 0.44
PARP11 Q9NR21 1/20 0.44
LMNA P02545 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1B1 Q16678 2/20 0.40
DHPS P49366 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
PIM1 P11309 1/20 0.39
CSNK1A1 P48729 1/20 0.39
CDK5 Q00535 1/20 0.39
ROCK1 Q13464 1/20 0.39
DYRK1A Q13627 1/20 0.39
LRRK2 Q5S007 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5811844 0.88 HTT (0.45) HTTMAPTMEN1KMT2APARP10
SCHEMBL5839984 0.85 ALDH1A1 (0.51) HTTMAPTMEN1KMT2APARP10
SCHEMBL2995748 0.84 ALDH1A1 (0.47) HTTMAPTMEN1KMT2APARP10
SCHEMBL3002188 0.82 HTT (0.44) HTTMAPTMEN1KMT2APOLB
SCHEMBL3651553 0.82 PARP10 (0.42) HTTMAPTMEN1KMT2APOLB
SCHEMBL3003289 0.82 PARP10 (0.42) HTTMAPTMEN1KMT2APARP10
SCHEMBL3007616 0.81 DRD2 (0.44) HTTMAPTMEN1KMT2APARP10
SCHEMBL3648486 0.81 PARP10 (0.44) HTTMAPTMEN1KMT2APOLB
SCHEMBL5839594 0.81 GRM2 (0.49) HTTPARP10PARP11LMNASMN1; SMN2
SCHEMBL3000762 0.81 DHPS (0.60) HTTMAPTMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7144894-B2 Sulfonamide bicyclic compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2006-12-05 US disclosed
US-20060063799-A1 Sulfonamide bicyclic compounds BRISTOL-MYERS SQUIBB COMPANY 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063799-A1 Sulfonamide bicyclic compounds APP, BACE1, IAPP HTT 242/4885MAPT 20/4885MEN1 2317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.